Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serum sialic acid level in diabetic retinopathy.
Akbri MZ, Sheikh AS, Bhatti MS, Hussnain M, Chaudhry ZA. Akbri MZ, et al. Among authors: bhatti ms. J Ayub Med Coll Abbottabad. 2001 Jan-Mar;13(1):29-30. J Ayub Med Coll Abbottabad. 2001. PMID: 11706637
Lipid profile in obesity.
Bhatti MS, Akbri MZ, Shakoor M. Bhatti MS, et al. J Ayub Med Coll Abbottabad. 2001 Jan-Mar;13(1):31-3. J Ayub Med Coll Abbottabad. 2001. PMID: 11706638
Pharmacodynamic Effects of Ticagrelor Dosing Regimens in Patients on Maintenance Ticagrelor Therapy: Results From a Prospective, Randomized, Double-Blind Investigation.
Cho JR, Rollini F, Franchi F, DeGroat C, Bhatti M, Dunn EC, Ferrante E, Muniz-Lozano A, Suryadevara S, Zenni MM, Guzman LA, Bass TA, Angiolillo DJ. Cho JR, et al. JACC Cardiovasc Interv. 2015 Jul;8(8):1075-1083. doi: 10.1016/j.jcin.2015.02.022. Epub 2015 Jun 24. JACC Cardiovasc Interv. 2015. PMID: 26117466 Free article. Clinical Trial.
Impact of Escalating Loading Dose Regimens of Ticagrelor in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Results of a Prospective Randomized Pharmacokinetic and Pharmacodynamic Investigation.
Franchi F, Rollini F, Cho JR, Bhatti M, DeGroat C, Ferrante E, Dunn EC, Nanavati A, Carraway E, Suryadevara S, Zenni MM, Guzman LA, Bass TA, Angiolillo DJ. Franchi F, et al. JACC Cardiovasc Interv. 2015 Sep;8(11):1457-1467. doi: 10.1016/j.jcin.2015.02.030. JACC Cardiovasc Interv. 2015. PMID: 26404199 Free article. Clinical Trial.
Cigarette smoking and antiplatelet effects of aspirin monotherapy versus clopidogrel monotherapy in patients with atherosclerotic disease: results of a prospective pharmacodynamic study.
Rollini F, Franchi F, Cho JR, Degroat C, Bhatti M, Ferrante E, Patel R, Darlington A, Tello-Montoliu A, Desai B, Ferreiro J, Muniz-Lozano A, Zenni MM, Guzman LA, Bass TA, Angiolillo DJ. Rollini F, et al. J Cardiovasc Transl Res. 2014 Feb;7(1):53-63. doi: 10.1007/s12265-013-9535-3. Epub 2014 Jan 7. J Cardiovasc Transl Res. 2014. PMID: 24395495
Effects of dabigatran on the cellular and protein phase of coagulation in patients with coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel. Results from a prospective, randomised, double-blind, placebo-controlled study.
Franchi F, Rollini F, Cho JR, King R, Phoenix F, Bhatti M, DeGroat C, Tello-Montoliu A, Zenni MM, Guzman LA, Bass TA, Ajjan RA, Angiolillo DJ. Franchi F, et al. Thromb Haemost. 2016 Mar;115(3):622-31. doi: 10.1160/TH15-06-0467. Epub 2015 Dec 3. Thromb Haemost. 2016. PMID: 26633836 Clinical Trial.
A head-to-head pharmacodynamic comparison of prasugrel vs. ticagrelor after switching from clopidogrel in patients with coronary artery disease: results of a prospective randomized study.
Rollini F, Franchi F, Cho JR, DeGroat C, Bhatti M, Muniz-Lozano A, Singh K, Ferrante E, Wilson RE, Dunn EC, Zenni MM, Guzman LA, Bass TA, Angiolillo DJ. Rollini F, et al. Eur Heart J. 2016 Sep 14;37(35):2722-30. doi: 10.1093/eurheartj/ehv744. Epub 2016 Feb 3. Eur Heart J. 2016. PMID: 26848148 Clinical Trial.
52 results